SEC Form 4 · accession 0000899243-19-003022
Kodiak Sciences Inc. · KOD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Hong Liang
Officer — See Remarks
Period of report
Feb 7, 2019
Accepted (ET)
Feb 8, 2019 · 4:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001468748
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 7, 2019 | M | 80,000 | $1.04 | A | 100,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $1.04 | Feb 7, 2019 | M | 80,000 | D | — | Jun 23, 2026 | Common Stock | 80,000 | 32,000 | D |
Explanation of responses
- F1The Reporting Person entered into a Lock-up Agreement in favor of the underwriters of the Company's initial public offering in October 2018 (the "Lock-up"). The terms of the Lock-up permit the exercise of options by the Reporting Person for cash and the shares of common stock issued as a result of the exercise are subject to the terms of the Lock-up. No shares of common stock were sold by the Reporting Person in connection with the exercise.
- F2The Reporting Person was originally granted an option to purchase 132,000 shares. Twenty-Five percent of the shares subject to the option vested on December 7, 2016, and 1/48th of the shares subject to the option vest on the same day of each month thereafter. On August 30, 2018, the Reporting Person exercised 20,000 of those shares and on February 7, 2019, the Reporting Person exercised 80,000 of those shares.
Remarks
Senior Vice President, Discovery Medicine